IONIS PHARMACEUTICALS INC Quarterly Other Assets, Current in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Ionis Pharmaceuticals Inc quarterly Other Assets, Current history and growth rate from Q2 2010 to Q2 2024.
  • Ionis Pharmaceuticals Inc Other Assets, Current for the quarter ending June 30, 2024 was $195M, a 9.47% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $195M +$16.8M +9.47% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $174M +$14.3M +8.98% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $184M +$16.2M +9.63% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $181M +$37.9M +26.5% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $178M +$35.1M +24.6% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $160M +$9.15M +6.08% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $168M +$24.9M +17.4% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $143M +$6.53M +4.78% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $143M +$11.7M +8.94% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $151M +$26.8M +21.6% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $143M +$3.21M +2.29% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $137M -$9.99M -6.81% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $131M +$30K +0.02% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $124M +$1.36M +1.11% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $140M +$324K +0.23% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $147M +$27.8M +23.4% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $131M +$28.9M +28.4% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $122M +$23.8M +24.1% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $140M +$37.4M +36.5% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $119M +$21.7M +22.3% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $102M +$25.1M +32.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $98.7M +$36.6M +59% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $102M +$29.4M +40.2% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $97.1M +$48.2M +98.5% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $77M +$25.5M +49.4% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $62.1M +$36.1M +139% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 $73.1M +$55.9M +325% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $48.9M +$33.7M +221% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $51.5M +$34.3M +199% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $25.9M +$8.53M +49% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $17.2M +$2.4M +16.3% Dec 31, 2016 10-K 2018-02-28
Q3 2016 $15.2M -$13.8M -47.6% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $17.3M -$12.6M -42.2% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $17.4M +$4.25M +32.3% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $14.8M -$918K -5.85% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $29.1M +$20.7M +248% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $29.9M +$21.3M +249% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $13.2M +$3.34M +34% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $15.7M +$8.17M +109% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $8.35M +$981K +13.3% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $8.57M +$2.78M +48.1% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $9.81M +$1.74M +21.6% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 $7.52M -$1.21M -13.9% Dec 31, 2013 10-K 2015-03-02
Q3 2013 $7.37M -$428K -5.49% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $5.79M +$62K +1.08% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $8.07M +$657K +8.86% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 $8.73M +$3.31M +61.2% Dec 31, 2012 10-K 2014-03-03
Q3 2012 $7.8M +$247K +3.27% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $5.72M -$1.89M -24.8% Jun 30, 2012 10-Q 2012-08-06
Q1 2012 $7.42M +$41K +0.56% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $5.42M -$1.64M -23.3% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $7.55M +$1.24M +19.7% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $7.61M +$590K +8.4% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $7.38M Mar 31, 2011 10-Q 2011-05-06
Q4 2010 $7.06M Dec 31, 2010 10-K 2012-02-29
Q3 2010 $6.31M Sep 30, 2010 10-Q 2010-11-05
Q2 2010 $7.02M Jun 30, 2010 10-Q 2010-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.